Prostate Cancer

eISSN: 2090-312XpISSN: 2090-3111
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
2.3
H-Index
14
SJR
Q3Urology
SNIP
0.71

Journal Specifications

Overview
  • Publisher
    HINDAWI LTD
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    USD 925
  • Publication Time
    13
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Prostate cancer
Overall survival
Progression-free survival
Prostate-specific antigen
Allele
Nanosomal Docetaxel Lipid Suspension
Prostate cancer screening

Recently Published Papers

Year-wise Publication

FAQs

Since when has Prostate Cancer been publishing? Faqs

The Prostate Cancer has been publishing since 2011 till date.

How frequently is the Prostate Cancer published? Faqs

Prostate Cancer is published Continuous publication.

What is the H-index. SNIP score, Citescore and SJR of Prostate Cancer? Faqs

Prostate Cancer has a H-index score of 14, Citescore of 2.3, SNIP score of 0.71, & SJR of Q3

Who is the publisher of Prostate Cancer? Faqs

The publisher of Prostate Cancer is HINDAWI LTD.

How can I view the journal metrics of Prostate Cancer on editage? Faqs

For the Prostate Cancer metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Prostate Cancer? Faqs

The eISSN number is 2090-312X and pISSN number is 2090-3111 for Prostate Cancer.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Prostate cancer, Overall survival, Progression-free survival, Prostate-specific antigen, Allele, Nanosomal Docetaxel Lipid Suspension, Prostate cancer screening.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.